ÌÇÐÄÆƽâ°æ

The Brazilian group NC Farma which includes companies such as EMS, Germend, and Legrand, was the leading pharmaceutical group in Brazil in 2023, with a revenue of around **** billion Brazilian reals generated from March 2022 to March 2023. Hypera Pharma and Eurofarma, both multinationals headquartered in São Paulo followed, with around **** and billion reals, respectively.

Brazil in the global pharmaceutical market

Brazil was among the leading pharmaceutical markets worldwide in 2023, with a market share of around *** percent. The segment with the highest market revenue was oncology drugs, followed by vaccines and anti-diabetic drugs. In 2023, oncology drugs accounted for nearly a of the revenue generated in the market. 

Brazilian pharmaceutical industry

The manufacturing industry is one of the main sectors of Brazil’s economy, and makes up approximately ** percent of the country’s gross domestic product as of 2023. The pharmaceutical segment is no exception: with a production value of more than ** billion Brazilian reals in 2020, the drug production market employed almost *** thousand people that same year. For instance, only in the wholesale segment, the pharma sector was responsible for billion Brazilian reals spent on salaries and remuneration.